Cardiovascular-related hospital visits amongst oncology patients receiving immune checkpoint inhibitors: A population-based cohort study
{{output}}
Introduction: Immune checkpoint inhibitors (ICIs) have substantially improved the clinical outcomes for many cancer patients. However, these treatments are potentially associated with serious cardiovascular adverse events. ... ...
